Utilization of risk-based predictive stability within regulatory submissions; industry’s experience
Open Access
- 11 May 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in AAPS Open
- Vol. 6 (1), 1-11
- https://doi.org/10.1186/s41120-020-00034-7
Abstract
Risk-Based Predictive Stability (RBPS) tools, such as the Accelerated Stability Assessment Program (ASAP) and other models, are used routinely within pharmaceutical development to quickly assess stability characteristics, especially to understand mechanisms of degradation. These modeling tools provide stability insights within weeks that could take months or years to understand using long-term stability conditions only. Despite their usefulness, the knowledge gained through these tools are not as broadly used to support regulatory filing strategies. This paper aims to communicate how industry has used RBPS data to support regulatory submissions and discuss the regulatory feedback that was received.Keywords
This publication has 8 references indexed in Scilit:
- A comparison of drug substance predicted chemical stability with ICH compliant stability studiesDrug Development and Industrial Pharmacy, 2018
- Accelerated Predictive StabilityPublished by Elsevier BV ,2018
- AAPS Workshop: accelerating pharmaceutical development through predictive stability approaches, April 4–5, 2016AAPS Open, 2017
- Prediction of the changes in drug dissolution from an immediate-release tablet containing two active pharmaceutical ingredients using an accelerated stability assessment program (ASAPprime®)AAPS Open, 2016
- An improved methodology for data analysis in accelerated stability studies of peptide drugs: Practical considerationsTalanta, 2012
- PQLI Application of Science- and Risk-based Approaches (ICH Q8, Q9, and Q10) to Existing ProductsJournal of Pharmaceutical Innovation, 2009
- Improved Protocol and Data Analysis for Accelerated Shelf-Life Estimation of Solid Dosage FormsPharmaceutical Research, 2007
- Accelerated aging: Prediction of chemical stability of pharmaceuticalsInternational Journal of Pharmaceutics, 2005